JUN 15, 2017 5:55 AM PDT

New Research on Huntington's Disease

While there are many neurodegenerative diseases that can devastate patients and families, Huntington’s disease remains one of the more severe conditions to impact the brain, and, in turn, the lives of family members and patients who must deal with it. Huntington’s disease is a progressive neurodegenerative disorder that shows up in patients between the ages of 30-50. The main manifestation of the disease is dementia. It creeps up slowly, gradually increasing in severity and ultimately leads to the patient needing full-time nursing care. The incidence of Huntington’s is one about every 10,000 to 15,000 people globally.

Huntington’s disease is genetic, and is caused by a mutation on the HD gene (also called the HTT gene) which is carried on chromosome 4. It’s what is known as an “autosomal dominant disease” which means that a single inherited gene that is defective will cause the disease to develop.

Mark Bevan, PhD, professor of Physiology at Northwestern University Feinberg School of Medicine and first author of the recent research at the university explained that while the roots of the disease are known, there is still much work to be done to figure out the underlying mechanisms of how it progresses. He stated, “Although the genetic basis of the disease is well established, why the mutation leads to the expression of symptoms and loss of brain tissue remains poorly understood.”

The symptoms of Huntington’s disease show up in adulthood, often in the patients who are young and in the prime of health. They involve a loss of motor and cognitive function, depression and personality changes. Once the disease has taken hold, symptoms will continue to get worse, usually over a period of 10-25 years, making it excruciating for families and patients to deal with. It’s always fatal, and death is often from complications of the disease including organ failure and infection.

Bevan explained that his study focused on the subthalamic nucleus, which is an area that has been overlooked in previous studies. He wrote, “While research into Huntington’s disease has focused on other parts of the basal ganglia, the subthalamic nucleus has been largely overlooked. This is surprising because patients with Huntington’s disease have fewer nerve cells in the subthalamic nucleus. People who have suffered damage to the subthalamic nucleus exhibit excessive movement and impulsive behavior, similar to patients with Huntington’s disease.”

The research involved mice, who had been genetically altered to carry the Huntington’s mutation. In the mouse model it was shown that the electrical activity of the subthalamic nucleus was essentially gone. In addition, there was “impaired anomalous receptor signaling, leading to defective energy metabolism and accumulation of damaging oxidants.” What all this means is that a new region of the brain has yielded clues to the progressive degeneration of tissue that happens in Huntington’s disease. With the mouse model showing similar pathology to what happens in humans with Huntington’s, there is now a new way forward in research into Huntington’s. There is currently no cure for the disease and treatments are limited in the symptoms they can relieve. With more research into brain signaling, hopefully a new target for treatments can be developed. Check out the video below to learn more about the research and what scientists can look at in future projects seeking information and answers to this devastating neurological condition.

Sources: Northwestern, UPI, eLife, Your Genome 

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 15, 2021
Infographics
Ketamine's Effects on Pain and Mental Health
JUL 15, 2021
Ketamine's Effects on Pain and Mental Health
Ketamine is receiving increasing amount of attention both for its effects in mental health- particularly in depression- ...
JUL 05, 2021
Cannabis Sciences
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
JUL 05, 2021
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
Researchers from Canada have found that long-term use of cannabidiol (CBD) is linked to improved symptoms of pain, anxie ...
JUL 12, 2021
Health & Medicine
Is Caffeine Good or Bad for Migraines?
JUL 12, 2021
Is Caffeine Good or Bad for Migraines?
The short answer is it's still not certain if caffeine helps or worsens migraines, but chronic consumption of caffei ...
JUL 23, 2021
Neuroscience
Researchers Switch Fear Response 'On' and 'Off' in Mice
JUL 23, 2021
Researchers Switch Fear Response 'On' and 'Off' in Mice
The fear response can be switched 'on' and 'off' in mice by targeting certain cells in the brain with pu ...
JUL 29, 2021
Health & Medicine
CBD Linked WIth Better Quality of Life in Epilepsy Patients
JUL 29, 2021
CBD Linked WIth Better Quality of Life in Epilepsy Patients
People with epilepsy report better well-being when they self-medicate with cannabidiol (CBD) according to a new study pu ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
Loading Comments...